Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 10-2019 | 10-2018 | 10-2017 | 10-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,959 | -2,988 | -2,874 | -2,019 | -1,886 |
| Depreciation Amortization | 168 | 46 | 50 | 31 | 6 |
| Accounts receivable | 9 | 81 | 49 | -60 | -9 |
| Other Working Capital | 642 | -184 | -110 | 170 | -565 |
| Other Operating Activity | 210 | -109 | -158 | -218 | 528 |
| Operating Cash Flow | $-2,930 | $-3,154 | $-3,043 | $-2,096 | $-1,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -18 | -89 | -193 | -15 |
| Sale Of Investment | 1,488 | -749 | 3 | -230 | 1,472 |
| Purchase Sale Intangibles | -744 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -744 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $740 | $-768 | $-86 | $-422 | $1,457 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 721 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,651 | 3,573 | 2,181 | 360 | 3,361 |
| Other Financing Activity | 420 | 392 | 258 | 191 | 870 |
| Financing Cash Flow | $3,792 | $3,965 | $2,439 | $551 | $4,231 |
| Beginning Cash Position | 1,337 | 1,309 | 2,042 | 3,978 | 160 |
| End Cash Position | 2,938 | 1,352 | 1,352 | 2,010 | 3,922 |
| Net Cash Flow | $1,601 | $44 | $-690 | $-1,968 | $3,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,930 | -3,154 | -3,043 | -2,096 | -1,926 |
| Capital Expenditure | -4 | -18 | -89 | -193 | -15 |
| Free Cash Flow | -2,935 | -3,173 | -3,133 | -2,289 | -1,941 |